Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for October 6th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, October 6th:

Capital Product Partners L.P. (CPLP - Free Report) : This shipping company that provides marine transportation services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 3.3% over the last 60 days.

Capital Product Partners has a price-to-earnings ratio (P/E) of 4.39, compared with 4.90 for the industry. The company possesses a Value Score of A.

AMC Networks Inc. (AMCX - Free Report) : This cable television's brands delivering content to audiences, and a platform owner and operator has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 3% over the last 60 days.

AMC Networks Inc. Price and Consensus

AMC Networks Inc. Price and Consensus

AMC Networks Inc. price-consensus-chart | AMC Networks Inc. Quote

 

AMC Networks has a price-to-earnings ratio (P/E) of 4.44, compared with 5.90 for the industry. The company possesses a Value Score of A.

AMC Networks Inc. PE Ratio (TTM)

AMC Networks Inc. PE Ratio (TTM)

AMC Networks Inc. pe-ratio-ttm | AMC Networks Inc. Quote

 

Danaos Corporation (DAC - Free Report) : This containerships owner and operator has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 10.8% over the last 60 days.

Danaos Corp has a price-to-earnings ratio (P/E) of 1.31, compared with 5.10 for the industry. The company possesses a Value Score of A.

Danaos Corporation PE Ratio (TTM)

Danaos Corporation PE Ratio (TTM)

Danaos Corporation pe-ratio-ttm | Danaos Corporation Quote

 

Sally Beauty Holdings, Inc. (SBH - Free Report) : This specialty retailer and distributor of professional beauty supplies has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 0.9% over the last 60 days.

Sally Beauty has a price-to-earnings ratio (P/E) of 4.49, compared with 21.50 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>